On Tuesday, Clearside Biomedical Inc (NASDAQ: CLSD) opened lower -33.33% from the last session, before settling in for the closing price of $0.9. Price fluctuations for CLSD have ranged from $0.80 to $17.10 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 10.40% annually for the last half of the decade. Company’s average yearly earnings per share was noted 34.04% at the time writing. With a float of $4.17 million, this company’s outstanding shares have now reached $5.23 million.
Clearside Biomedical Inc (CLSD) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Clearside Biomedical Inc is 20.29%, while institutional ownership is 12.59%. The most recent insider transaction that took place on Feb 24 ’25, was worth 13,800. In this transaction Director of this company bought 15,000 shares at a rate of $0.92, taking the stock ownership to the 176,141 shares.
Clearside Biomedical Inc (CLSD) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -1.5 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -1.55) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.98 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 34.04% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 22.36% during the next five years compared to 10.40% growth over the previous five years of trading.
Clearside Biomedical Inc (NASDAQ: CLSD) Trading Performance Indicators
Check out the current performance indicators for Clearside Biomedical Inc (CLSD). In the past quarter, the stock posted a quick ratio of 2.98. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.06, a number that is poised to hit -17.10 in the next quarter and is forecasted to reach -3.30 in one year’s time.
Technical Analysis of Clearside Biomedical Inc (CLSD)
Let’s dig in a bit further. During the last 5-days, its volume was 1.31 million. That was better than the volume of 0.13 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 4.55%.
During the past 100 days, Clearside Biomedical Inc’s (CLSD) raw stochastic average was set at 0.08%, which indicates a significant decrease from 0.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.3141 in the past 14 days, which was lower than the 0.6171 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.7290, while its 200-day Moving Average is $9.1795. However, in the short run, Clearside Biomedical Inc’s stock first resistance to watch stands at $0.7448. Second resistance stands at $0.8896. The third major resistance level sits at $0.9670. If the price goes on to break the first support level at $0.5226, it is likely to go to the next support level at $0.4452. The third support level lies at $0.3004 if the price breaches the second support level.
Clearside Biomedical Inc (NASDAQ: CLSD) Key Stats
There are currently 5,234K shares outstanding in the company with a market cap of 3.14 million. Presently, the company’s annual sales total 1,660 K according to its annual income of -34,350 K. Last quarter, the company’s sales amounted to 200 K and its income totaled -5,970 K.
